Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Genya Hamano is active.

Publication


Featured researches published by Genya Hamano.


Journal of Hepato-biliary-pancreatic Sciences | 2014

Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan.

Shoji Kubo; Yasuni Nakanuma; Shigekazu Takemura; Chikaharu Sakata; Yorihisa Urata; Akinori Nozawa; Takayoshi Nishioka; Masahiko Kinoshita; Genya Hamano; Hiroaki Terajima; Gorou Tachiyama; Yuji Matsumura; Terumasa Yamada; Hiromu Tanaka; Shoji Nakamori; Akira Arimoto; Norifumi Kawada; Masahiro Fujikawa; Hiromitsu Fujishima; Yasuhiko Sugawara; Shogo Tanaka; Hideyoshi Toyokawa; Yuko Kuwae; Masahiko Ohsawa; Shinichiro Uehara; Kyoko Kogawa Sato; Tomoshige Hayashi; Ginji Endo

An outbreak of cholangiocarcinoma occurred among workers in the offset color proof‐printing department at a printing company in Japan. The aim of this study was to clarify the characteristics of the patients with cholangiocarcinoma.


Journal of Hepato-biliary-pancreatic Sciences | 2014

Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma

Shoji Kubo; Masahiko Kinoshita; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Genya Hamano; Tokuji Ito; Makoto Abue; Masaru Aoki; Kei Nakagawa; Michiaki Unno; Susumu Hijioka; Toshihisa Fujiyoshi; Yasuhiro Shimizu; Toru Mizuguchi; Ken Shirabe; Akihiro Nishie; Yoshinao Oda; Kenji Takenaka; Tomonari Kobarai; Terumasa Hisano; Akio Saiura; Hiroshi Numao; Mayura Toda; Yuko Kuwae; Yasuni Nakanuma; Ginji Endo

Cholangiocarcinoma has been reported in workers exposed to chlorinated organic solvents and has consequently been classified as an occupational disease (occupational cholangiocarcinoma) by the Japanese Ministry of Health, Labour and Welfare. This study aimed to identify the characteristics of nine workers newly diagnosed with occupational cholangiocarcinoma.


Journal of Occupational Health | 2014

Changes in Laboratory Test Results and Diagnostic Imaging Presentation before the Detection of Occupational Cholangiocarcinoma

Shoji Kubo; Shigekazu Takemura; Chikaharu Sakata; Yorihisa Urata; Takayoshi Nishioka; Akinori Nozawa; Masahiko Kinoshita; Genya Hamano; Yasuni Nakanuma; Ginji Endo

Changes in Laboratory Test Results and Diagnostic Imaging Presentation before the Detection of Occupational Cholangiocarcinoma: Shoji KUBO, et al. Department of Hepato‐Biliary‐Pancreatic Surgery, Osaka City University Graduate School of Medicine—


World Journal of Gastroenterology | 2015

Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.

Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Akinori Nozawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Yorihisa Urata

Although liver resection is considered the most effective treatment for hepatocellular carcinoma (HCC), treatment outcomes are unsatisfactory because of the high rate of HCC recurrence. Since we reported hepatitis B e-antigen positivity and high serum hepatitis B virus (HBV) DNA concentrations are strong risk factors for HCC recurrence after curative resection of HBV-related HCC in the early 2000s, many investigators have demonstrated the effects of viral status on HCC recurrence and post-treatment outcomes. These findings suggest controlling viral status is important to prevent HCC recurrence and improve survival after curative treatment for HBV-related HCC. Antiviral therapy after curative treatment aims to improve prognosis by preventing HCC recurrence and maintaining liver function. Therapy with interferon and nucleos(t)ide analogs may be useful for preventing HCC recurrence and improving overall survival in patients who have undergone curative resection for HBV-related HCC. In addition, reactivation of viral replication can occur after liver resection for HBV-related HCC. Antiviral therapy can be recommended for patients to prevent HBV reactivation. Nevertheless, further studies are required to establish treatment guidelines for patients with HBV-related HCC.


European Surgical Research | 2015

Outcomes of Pure Laparoscopic versus Open Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients: A Case-Control Study with Propensity Score Matching

Shogo Tanaka; Shigekazu Takemura; Hiroji Shinkawa; Takayoshi Nishioka; Genya Hamano; Masahiko Kinoshita; Tokuji Ito; Shoji Kubo

Background/Purpose: Laparoscopic hepatic resection (LH) for hepatocellular carcinoma (HCC) has gradually gained ground as a safe and minimally invasive treatment, although LH for cirrhotic patients remains challenging. Methods: Between January 2007 and August 2014, 28 and 57 patients with histologically proven cirrhosis (histological activity index, fibrosis score 4) underwent pure LH and open hepatic resection (OH; less than segmentectomy), respectively, for peripheral HCC ≤5 cm. To correct the difference in clinicopathological factors, including difficulty scores, between the two groups, propensity score matching was used at a 1:1 ratio, which resulted in a comparison of 20 patients per group. We compared the short- and long-term outcomes of LH and OH to investigate the efficacy of LH. Results: Clinicopathological variables, including difficulty scores, were well balanced between the two groups. The incidence of complications and mean intraoperative blood loss were lower in the LH group than the OH group (0 vs. 45% and 180 vs. 440 ml, p = 0.001 and 0.04, respectively). The 3-year disease-free survival rate was 42% in the LH group and 30% in the OH group (p = 0.533), whereas the 5-year overall survival rates were 46 and 60%, respectively (p = 0.606). Conclusions: LH is a safe and effective treatment option for cirrhotic patients with HCC in terms of intraoperative blood loss and morbidity.


Journal of Hepato-biliary-pancreatic Sciences | 2016

Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma

Masahiko Kinoshita; Shoji Kubo; Yasuni Nakanuma; Yasunori Sato; Shigekazu Takemura; Shogo Tanaka; Genya Hamano; Tokuji Ito; Hiroaki Terajima; Terumasa Yamada; Shoji Nakamori; Akira Arimoto; Masahiro Fujikawa; Yasuhiko Sugawara; Takatsugu Yamamoto; Makoto Abue; Kei Nakagawa; Michiaki Unno; Toru Mizuguchi; Kenji Takenaka; Ken Shirabe; Toshihiko Shibata

We aimed to identify the pathological characteristics of occupational cholangiocarcinoma.


Journal of Medical Case Reports | 2011

One-stage laparoscopic-assisted resection of gastrojejunocolic fistula after gastrojejunostomy for duodenal ulcer: a case report

Masashi Takemura; Genya Hamano; Takayoshi Nishioka; Mamiko Takii; Katsuyuki Mayumi; Takashi Ikebe

IntroductionGastrojejunocolic fistula is a rare condition after gastrojejunostomy. It was thought to be a late complication related to stomal ulcers as a result of inadequate gastrectomy or incomplete vagotomy. We report a case of gastrojejunocolic fistula after gastrojejunostomy for peptic ulcer treated with one-stage laparoscopic resection.Case presentationA 41-year-old Japanese man complained of diarrhea for 10 months, as well as severe weight loss and weakness. After admission, we immediately started intravenous hyperalimentation. On performing colonoscopy and barium swallow, gastrojejunocolic fistula was observed close to the gastrojejunostomy site leading to the transverse colon. After our patients nutritional status had improved, one-stage surgical intervention was performed laparoscopically. After the operation, our patient recovered uneventfully and his body weight increased by 5 kg within three months.ConclusionsModern management of gastrojejunocolic fistula is a one-stage resection because of the possibility of early recovery from malnutrition using parenteral nutritional methods. Today, laparoscopic one-stage en bloc resection may be feasible for patients with gastrojejunocolic fistula due to the development of laparoscopic instruments and procedures. We describe the first case of gastrojejunocolic fistula treated laparoscopically by one-stage resection and review the literature.


Surgery Today | 2016

Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents

Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Takayoshi Nishioka; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Takatsugu Yamamoto; Makoto Abue; Masaru Aoki; Kei Nakagawa; Susumu Hijioka; Atsushi Miyamoto; Yukio Osaki; Ginji Endo; Shinji Kumagai

PurposeThis study aimed to establish an efficient strategy for screening and surveillance for occupational cholangiocarcinoma.MethodsWe evaluated the consecutive changes in laboratory findings during regular health examinations and in abdominal ultrasonography findings before the diagnosis of occupational cholangiocarcinoma in nine patients. The results of laboratory tests and abdominal ultrasonography at the time of diagnosis were also examined.ResultsIn all patients, the serum γ-glutamyl transpeptidase (γ-GTP) activity increased several years before the diagnosis of cholangiocarcinoma. The serum alanine aminotransferase (ALT) activity also increased several years before the diagnosis, following an increase in the serum aspartate aminotransferase (AST) activity in most patients. Abdominal ultrasonography before the diagnosis revealed regional dilatation of the bile ducts, which continued to enlarge. At the time of diagnosis, the γ-GTP, AST, and ALT activities were increased in nine, seven, and seven patients, respectively. The regional dilatation of bile ducts without tumor-induced stenosis, dilated bile ducts due to tumor-induced stenosis, space-occupying lesions, and/or lymph node swelling were observed. The serum concentrations of carbohydrate antigen 19-9 (CA 19-9) and/or carcinoembryonic antigen (CEA) were increased in all patients.ConclusionsRegular health examinations with a combination of ultrasonography and laboratory tests including the γ-GTP, AST, ALT, CA 19-9, and CEA levels are useful for screening and surveillance for occupational cholangiocarcinoma.


Journal of Surgical Oncology | 2016

The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case-control study.

Masahiko Kinoshita; Shoji Kubo; Shogo Tanaka; Shigekazu Takemura; Takayoshi Nishioka; Genya Hamano; Tokuji Ito; Sayaka Tanaka; Masahiko Ohsawa; Toshihiko Shibata

This study aimed to investigate the association between non‐alcoholic steatohepatitis (NASH) and intrahepatic cholangiocarcinoma (ICC).


Journal of Hepato-biliary-pancreatic Sciences | 2016

Outcomes after resection of occupational cholangiocarcinoma

Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Masaki Koda; Takanori Aota; Takatsugu Yamamoto; Hiroaki Terajima; Gorou Tachiyama; Terumasa Yamada; Shoji Nakamori; Akira Arimoto; Masahiro Fujikawa; Yoshito Tomimaru; Yasuhiko Sugawara; Kei Nakagawa; Michiaki Unno; Toru Mizuguchi; Kenji Takenaka; Koichi Kimura; Ken Shirabe; Akio Saiura; Katsuhiko Uesaka; Hiroki Taniguchi; Akira Fukuda; Ja-Mun Chong; Yuko Kuwae

Cholangiocarcinoma caused by exposure to 1,2‐dichloropropane and/or dichloromethane is recognized as occupational cholangiocarcinoma. The aim of this study was to investigate the outcomes after resection of occupational cholangiocarcinoma to establish a treatment strategy for this disease.

Collaboration


Dive into the Genya Hamano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge